Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Effect of Nafamostat Mesylate in Patients With COVID-19 Pneumonia: Open Labelled Randomized Controlled Clinical Trial

NCT04418128 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.

NCT NCT04418128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04418128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Effect of Nafamostat Mesylate in Patients With COVID-19 Pneumonia: Open Labelled Randomized Controlled Clinical Trial
Lead sponsor
Gyeongsang National University Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 10, 2020
Completion date
April 30, 2021
Enrollment
84 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid-19